Your browser doesn't support javascript.
loading
Human prion disease surveillance in Spain, 1993-2018: an overview.
De Pedro-Cuesta, Jesús; Almazán-Isla, Javier; Tejedor-Romero, Laura; Ruiz-Tovar, María; Avellanal, Fuencisla; Rábano, Alberto; Calero, Miguel; García López, Fernando J.
Afiliação
  • De Pedro-Cuesta J; Department of Neurodegeneration, Ageing and Mental Health, National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
  • Almazán-Isla J; Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Tejedor-Romero L; Department of Neurodegeneration, Ageing and Mental Health, National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
  • Ruiz-Tovar M; Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • Avellanal F; Department of Neurodegeneration, Ageing and Mental Health, National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
  • Rábano A; Department of Neurodegeneration, Ageing and Mental Health, National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
  • Calero M; Consortium for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
  • García López FJ; Department of Neurodegeneration, Ageing and Mental Health, National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
Prion ; 15(1): 94-106, 2021 12.
Article em En | MEDLINE | ID: mdl-34120571
In Spain, human transmissible spongiform encephalopathies (TSEs) have been undergoing continuous surveillance for over 25 years. In 1995, the system was launched as an EU Concerted Action, with EU surveillance network procedures being incorporated from 2002 onwards. The aim of this report was to describe performance and outcomes of this surveillance system across the period 1993-2018. Neurology and public health specialists from every region reported cases to a central hub at the Carlos III Health Institute, Madrid. In all, eight accidentally transmitted cases and five definite variant Creutzfeldt-Jakob disease (vCJD) patients were reported. All vCJD cases were diagnosed between 2005 and 2008. Two of these were family/dietary-related and spatially linked to a third. Yearly incidence of sporadic CJD per million was 1.25 across the period 1998-2018, and displayed a north-south gradient with the highest incidence in La Rioja, Navarre and the Basque Country. Genetic TSEs were observed to be clustered in the Basque Country, with a 4-fold incidence over the national rate. A total of 120 (5.6%) non-TSE sporadic, conformational, rapidly progressing neurodegenerative and vascular brain disorders were reported as suspect CJD. We conclude that TSEs in Spain displayed geographically uneven, stable medium incidences for the sporadic and genetic forms, a temporal and spatial family cluster for vCJD, and decreasing numbers for dura-mater-associated forms. The vCJD surveillance, framed within the EU network, might require continuing to cover all prion disorders. There is need for further strategic surveillance research focusing on case definition of rapid-course, conformational encephalopathies and surgical risk.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Creutzfeldt-Jakob / Encefalopatia Espongiforme Bovina / Doenças Priônicas Tipo de estudo: Screening_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Creutzfeldt-Jakob / Encefalopatia Espongiforme Bovina / Doenças Priônicas Tipo de estudo: Screening_studies Limite: Animals / Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article